Tandon, R, Nasrallah, HA, Keshavan, MS. Schizophrenia, ‘just the facts’ 4. Clinical features and conceptualization. Schizophr Res
2009; 110: 1–23.
Zipursky, RB, Reilly, TJ, Murray, RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull
2013; 39: 1363–72.
McGorry, P, Johanessen, JO, Lewis, S, Birchwood, M, Malla, A, Nordentoft, M, et al. Early intervention in psychosis: keeping faith with evidence-based health care. Psychol Med
2010; 40: 399–404.
Craig, TKJ, Garety, P, Power, P, Rahaman, N, Colbert, S, Fornells-Ambrojo, M, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ
2004; 329: 1067.
Warner, R. Recovery from Schizophrenia: Psychiatry and Political Economy. Brunner-Routledge, 2004.
AlAqeel, B, Margolese, HC. Remission in schizophrenia: critical and systematic review. Harv Rev Psychiatry
2012; 20: 281–97.
Menezes, NM, Arenovich, T, Zipursky, RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med
2006; 36: 1349–62.
Hegarty, JD, Baldessarini, RJ, Tohen, M, Waternaux, C, Oepen, G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry
1994; 151: 1409–16.
Jaaskeläinen, E, Juola, P, Hirvonen, N, McGrath, JJ, Saha, S, Isohanni, M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull
2013; 39: 1296–306.
Henry, LP, Amminger, GP, Harris, MG, Yuen, HP, Harrigan, SM, Prosser, AL, et al. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J Clin Psychiatry
2010; 71: 716–28.
Morgan, C, Lappin, J, Heslin, M, Donoghue, K, Lomas, B, Reininghaus, U, et al. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 Study. Psychol Med
2014; 44: 2713–26.
Tang, JYM, Chang, WC, Hui, CLM, Wong, GHY, Chan, SKW, Lee, EHM, et al. Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study. Schizophr Res
2014; 153: 1–8.
Evensen, J, Rossberg, JI, Barder, H, Haahr, U, Hegelstad, WTV, Joa, I, et al. Flat affect and social functioning: a 10 year follow-up study of first episode psychosis patients. Schizophr Res
2012; 139: 99–104.
Andreasen, NC, Carpenter, WT, Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry
2005; 162: 441–9.
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000; 283: 2008–12.
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med
2009; 151: 264–9.
Warner, R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry
2009; 22: 374–80.
Leucht, S, Lasser, R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry
2006; 39: 161–70.
Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–34.
Duvall, S, Tweedie, R. A non-parametric ‘trim and fill’ method for assessing publication bias in meta-analysis. J Am Stat Assoc
2000; 95: 89–98.
Higgins, JP, Thompson, SG, Deeks, JJ, Altman, DG. Measuring inconsistency in meta-analyses. BMJ
2003; 327: 557–60.
Harrow, M, Grossman, LS, Jobe, TH, Herbener, ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull
2005; 31: 723–34.
Mojtabai, R, Susser, ES, Bromet, EJ. Clinical characteristics, 4-year course, and DSM-IV classification of patients with noneffective acute remitting psychosis. Am J Psychiatry
2003; 160: 2108–15.
Naz, B, Craig, TJ, Bromet, EJ, Finch, SJ, Fochtmann, U, Carlson, GA. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up. Psychol Med
2007; 37: 1173–81.
Carlson, GA, Bromet, EJ, Sievers, S. Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. Am J Psychiatry
2000; 157: 213–9.
Craig, TJ, Bromet, EJ, Fennig, S, Tanenberg-Karant, M, Lavelle, J, Galambos, N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?
Am J Psychiatry
2000; 157: 60–6.
Zarate, CA, Tohen, M, Land, ML. First-episode schizophreniform disorder: comparisons with first-episode schizophrenia. Schizophr Res
2000; 46: 31–4.
Tohen, M, Hennen, J, Zarate, CM, Baldessarini, RJ, Strakowski, SM, Stoll, AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry
2000; 157: 220–8.
Tohen, M, Khalsa, HMK, Salvatore, P, Vieta, E, Ravichandran, C, Baldessarini, RJ. Two-year outcomes in first-episode psychotic depression: the McLean-Harvard first-episode project. J Affect Disord
2012; 136: 1–8.
Simonsen, E, Friis, S, Opjordsmoen, S, Mortensen, EL, Haahr, U, Melle, I, et al. Early identification of non-remission in first-episode psychosis in a two-year outcome study. Acta Psychiatr Scand
2010; 122: 375–83.
Kua, J, Wong, KE, Kua, EH, Tsoi, WF. A 20-year follow-up study on schizophrenia in Singapore. Acta Psychiatr Scand
2003; 108: 118–25.
DeLisi, LE, Sakuma, M, Ge, S, Kushner, M. Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psychiatry Res Neuroimaging
1998; 84: 75–88.
Thara, R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can J Psychiatry
2004; 49: 564–9.
Kurihara, T, Kato, M, Reverger, R, Tirta, IG. Seventeen-year clinical outcome of schizophrenia in Bali. Eur Psychiatry
2011; 26: 333–8.
Alaghband-Rad, J, Boroumand, M, Amini, H, Sharifi, V, Omid, A, Davari-Ashtiani, R, et al. Non-affective acute remitting psychosis: a preliminary report from Iran. Acta Psychiatr Scand
2006; 113: 96–101.
Srivastava, AK, Stitt, L, Thakar, M, Shah, N, Chinnasamy, G. The abilities of improved schizophrenia patients to work and live independently in the community: a 10-year long-term outcome study from Mumbai, India. Ann Gen Hosp Psychiatry
2009; 8: 24.
Verma, S, Subramaniam, M, Abdin, E, Poon, LY, Chong, SA. Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr Scand
2012; 126: 282–9.
Helgason, L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented?
Acta Psychiatr scand
1990; 81: 231–5.
Wiersma, D, Wanderling, J, Dragomirecka, E, Ganev, K, Harrison, G, An Der Heiden, W, et al. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med
2000; 30: 1155–67.
Mason, P, Harrison, G, Glazebrook, C, Medley, I, Croudace, T. The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization. Br J Psychiatry
1996; 169: 580–6.
Vazquez-Barquero, JL, Cuesta, MJ, Herrera Castanedo, S, Lastra, I, Herran, A, Dunn, G. Cantabria first-episode schizophrenia study: three-year follow-up. Br J Psychiatry
1999; 174: 141–9.
Madsen, AL, Vorstrup, S, Rubin, P, Larsen, JK, Hemmingsen, R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand
1999; 100: 119–25.
Clarke, M, Whitty, P, Browne, S, McTigue, O, Kamali, M, Gervin, M, et al. Untreated illness and outcome of psychosis. Br J Psychiatry
2006; 189: 235–40.
Nyman, AK, Jonsson, H. Differential evaluation of outcome in schizophrenia. Acta Psychiatr Scand
1983; 68: 458–75.
Mattsson, M, Topor, A, Cullberg, J, Forsell, Y. Association between financial strain, social network and five-year recovery from first episode psychosis. Soc Psychiatry Psychiatr Epidemiol
2008; 43: 947–52.
Whitty, P, Clarke, M, McTigue, O, Browne, S, Kamali, M, Kinsella, A, et al. Predictors of outcome in first-episode schizophrenia over the first 4 years of illness. Psychol Med
2008; 38: 1141–6.
Hill, M, Crumlish, N, Clarke, M, Whitty, P, Owens, E, Renwick, L, et al. Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years. Schizophr Res
2012; 141: 215–21.
Rund, BR, Barder, HE, Evensen, J, Haahr, U, Hegelstad, WT, Joa, I, et al. Neurocognition and duration of psychosis: a 10-year follow-up of first-episode patients. Schizophr Bull
2016; 42: 87–95.
Langeveld, J, Joa, I, Friis, S, Ten Velden Hegelstad, W, Melle, I, Johannessen, JO, et al. A comparison of adolescent- and adult-onset first-episode, non-affective psychosis: 2-year follow-up. Eur Arch Psychiatry Clin Neurosci
2012; 262: 599–605.
Boden, R, Sundstrom, J, Lindstrom, E, Lindstrom, L. Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophr Res
2009; 107: 232–7.
Austin, SF, Mors, O, Secher, RG, Hjorthoj, CR, Albert, N, Bertelsen, M, et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res
2013; 150: 163–8.
Albert, N, Bertelsen, M, Thorup, A, Petersen, L, Jeppesen, P, Le Quach, P, et al. Predictors of recovery from psychosis. Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res
2011; 125: 257–66.
Bertelsen, M, Jeppesen, P, Petersen, L, Thorup, A, Ohlenschlaeger, J, Quach, PL, et al. Course of illness in a sample of 265 patients with first-episode psychosis – five-year follow-up of the Danish OPUS trial. Schizophr Res
2009; 107: 173–8.
Ceskova, E, Prikryl, R, Kasparek, T. Outcome in males with first-episode schizophrenia: 7-year follow-up. World J Biol Psychiatry
2011; 12: 66–72.
Thorup, A, Albert, N, Bertelsen, M, Petersen, L, Jeppesen, P, Le Quach, P, et al. Gender differences in first-episode psychosis at 5-year follow-up – two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry
2014; 29: 44–51.
Lambert, M, Schimmelmann, BG, Naber, D, Schacht, A, Karow, A, Wagner, T, et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry
2006; 67: 1690–7.
Wunderink, L, Sytema, S, Nienhuis, FJ, Wiersma, D. Clinical recovery in first-episode psychosis. Schizophr Bull
2009; 35: 362–9.
Lambert, M, Schimmelmann, BG, Schacht, A, Karow, A, Wagner, T, Wehmeier, PM, et al. Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years. Schizophr Res
2009; 107: 165–72.
Gasquet, I, Haro, JM, Tcherny-Lessenot, S, Chartier, F, Lepine, JP. Remission in the outpatient care of schizophrenia: 3-year results from the Schizophrenia Outpatients Health Outcomes (SOHO) study in France. Eur Psychiatry
2008; 23: 491–6.
Fraguas, D, del Rey-Mejias, T, Moreno, C, Castro-Fornieles, J, Graell, M, Otero, S, et al. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study. Schizophr Res
2014; 152: 130–8.
Torgalsboen, AK, Mohn, C, Czajkowski, N, Rund, BR. Relationship between neurocognition and functional recovery in first-episode schizophrenia: results from the second year of the Oslo multi-follow-up study. Psychiatry Res
2015; 227: 185–91.
Van Os, J, Fahy, TA, Jones, P, Harvey, I, Sham, P, Lewis, S, et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med
1996; 26: 161–76.
De Haan, L, Nimwegen, L, Amelsvoort, T, Dingemans, P, Linszen, D. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia. Pharmacopsychiatry
2008; 41: 125–8.
Shepherd, M, Watt, D, Falloon, I, Smeeton, N. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl
1989; 15: 1–46.
Jablensky, A, Sartorius, N, Ernberg, G, Anker, M, Korten, A, Cooper, JE, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl
1992; 20: 1–97.
Kinoshita, H, Nakane, Y, Nakane, H, Ishizaki, Y, Honda, S, Ohta, Y, et al. Nagasaki schizophrenia study: influence of the duration of untreated psychosis on long-term outcome. Acta Medica Nagasakiensia
2005; 50: 17–22.
Harrison, G, Hopper, K, Craig, T, Laska, E, Siegel, C, wanderling, J, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry
2001; 178: 506–17.
Kaleda, VG. The course and outcomes of episodic endogenous psychoses with juvenile onset (a follow-up study). Neurosci Behav Physiol
2009; 39: 873–84.
Bromet, EJ, Finch, SJ, Carlson, GA, Fochtmann, L, Mojtabai, R, Craig, TJ, et al. Time to remission and relapse after the first hospital admission in severe bipolar disorder. Soc Psychiatry Psychiatr Epidemiol
2005; 40: 106–13.
Alvarez-Jimenez, M, Gleeson, JF, Henry, LP, Harrigan, SM, Harris, MG, Killackey, E, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med
2012; 42: 595–606.
Ucok, A, Serbest, S, Kandemir, PE. Remission after first-episode schizophrenia: results of a long-term follow-up. Psychiatry Res
2011; 189: 33–7.
Emsley, R, Rabinowitz, J, Medori, R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res
2007; 89: 129–39.
Addington, J, Addington, D. Symptom remission in first episode patients. Schizophr Res
2008; 106: 281–5.
Perkins, DO, Lieberman, JA, Gu, H, Tohen, M, McEvoy, J, Green, AL, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry
2004; 185: 18–24.
Emsley, R, Oosthuizen, PP, Kidd, M, Koen, L, Niehaus, DJH, Turner, HJ. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry
2006; 67: 1707–12.
Salem, MO, Moselhy, HF, Attia, H, Yousef, S. Psychogenic psychosis revisited: a follow up study. Int J Health Sci (Qassim)
2009; 3: 45–9.
Jordan, G, Lutgens, D, Joober, R, Lepage, M, Iyer, SN, Malla, A. The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. J Clin Psychiatry
2014; 75: e566–72.
Manchanda, R, Norman, RMG, Malla, AK, Harricharan, R, Northcott, S. Persistent psychoses in first episode patients. Schizophr Res
2005; 80: 113–6.
Hassan, GAM, Taha, GRA. Long term functioning in early onset psychosis: two years prospective follow-up study. Behav Brain Funct
2011; 7: 28.
Norman, RMG, Manchanda, R, Windell, D. The prognostic significance of early remission of positive symptoms in first treated psychosis. Psychiatry Res
2014; 218: 44–7.
Benoit, A, Bodnar, M, Malla, AK, Joober, R, Bherer, L, Lepage, M. Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis. Schizophr Res
2014; 153: 103–8.
Lieberman, JA, Alvir, JMJ, Woerner, M, Degreef, G, Bilder, RM, Ashtari, M, et al. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull
1992; 18: 351–71.
Gignac, A, McGirr, A, Lam, RW, Yatham, LN. Course and outcome following a first episode of mania: four-year prospective data from the Systematic Treatment Optimization Program (STOP-EM). J Affect Disord
2015; 175: 411–7.
Rangaswamy, T. Twenty-five years of schizophrenia: the Madras longitudinal study. Indian J Psychiatry
2012; 54: 134–7.
Harrow, M, Sands, JR, Silverstein, ML, Goldberg, JF. Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr Bull
1997; 23: 287–303.
Wiersma, D, Nienhuis, FJ, Slooff, CJ, Giel, R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull
1998; 24: 75–85.
Chang, WC, Chan, TC, Chen, ES, Hui, CL, Wong, GH, Chan, SK, et al. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia. Schizophr Res
2013; 143: 107–15.
Aadamsoo, K, Saluveer, E, Kuunarpuu, H, Vasar, V, Maron, E. Diagnostic stability over 2 years in patients with acute and transient psychotic disorders. Nord J Psychiatry
2011; 65: 381–8.
Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry
2006; 189: 229–34.
Lieberman, JA, Alvir, JM, Koreen, A, Geisler, S, Chakos, M, Sheitman, B, et al. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology
1996; 14: 13S–21S.
Schimmelmann, BG, Conus, P, Cotton, S, Kupferschmid, S, McGorry, PD, Lambert, M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry
2012; 27: 463–9.
Chang, WC, Tang, JY, Hui, CL, Lam, MM, Chan, SK, Wong, GH, et al. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study. Aust NZ J Psychiatry
2012; 46: 100–8.
Shrivastava, A, Shah, N, Johnston, M, Stitt, L, Thakar, M. Predictors of long-term outcome of first-episode schizophrenia: a ten-year follow-up study. Indian J Psychiatry
2010; 52: 320–6.
Rangaswamy, T, Mangala, R, Mohan, G, Joseph, J, John, S. Intervention for first episode psychosis in India – the SCARF experience. Asian J Psychiatry
2012; 5: 58–62.
Johnson, S, Sathyaseelan, M, Charles, H, Jeyaseelan, V, Jacob, KS. Predictors of insight in first-episode schizophrenia: a 5-year cohort study from India. Int J Soc Psychiatry
2014; 60: 566–74.
Faber, G, Smid, HG, Van Gool, AR, Wunderink, L, van den Bosch, RJ, Wiersma, D. Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial. J Clin Psychiatry
2012; 73: 632–8.
Drake, RE, Latimer, E. Lessons learned in developing community mental health care in North America. World Psychiatry
2012; 11: 47–51.
Zipursky, RB, Agid, O. Recovery, not progressive deterioration, should be the expectation in schizophrenia. World Psychiatry
2015; 14: 94–6.
Lally, J, Ajnakina, O, Di Forti, M, Trotta, A, Demjaha, A, Kolliakou, A, et al. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychol Med
2016; 46: 3231–40.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry
2005; 62: 975–83.
Penttila, M, Jaaskelainen, E, Hirvonen, N, Isohanni, M, Miettunen, J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry
2014; 205: 88–94.
Dixon, LB, Holoshitz, Y, Nossel, I. Treatment engagement of individuals experiencing mental illness: review and update. World Psychiatry
2016; 15: 13–20.
Haro, JM, Novick, D, Bertsch, J, Karagianis, J, Dossenbach, M, Jones, PB. Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry
2011; 199: 194–201.